News
Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...
Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.
Moderna announced layoffs affecting 10% of its workforce amid government and competitive challenges to its vaccine business ...
Hosted on MSN29d
FDA gives full approval to Moderna COVID shot for at-risk kidsThe Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is ...
The U.S. Food and Drug Administration has granted full approval for Moderna's MRNA.O COVID-19 vaccine, Spikevax, in children ...
MRNA's second-quarter results are likely to spotlight a sharp decline in Spikevax sales, RSV uptake and key pipeline ...
(Moderna's COVID-19 vaccine for adults was fully approved in January 2022.) After all, the FDA can easily revoke an emergency use authorization at any time, which was seen as an unsustainable risk.
The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval to those with at least one underlying condition that puts them at risk ...
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease Written by moderna inc.
FDA clears Moderna’s RSV vaccine for use in people ages 18 to 59 By Helen Branswell STAT,Updated June 13, 2025, 2:37 p.m.
The FDA’s updates to their Moderna COVID-19 vaccine fact sheet also say it can be stored at room temperature for 24 hours now, an increase of 12 hours over previous recommendations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results